leucine has been researched along with Squamous Cell Carcinoma of Head and Neck in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hossain, MZ; Mohammed Alabsi, A; Mohd Bakri, M; Ramanathan, A; Syed Abdul Rahman, SN; Yahya, F | 1 |
| Niu, K; Wang, P; Yu, S; Zhu, Z | 1 |
2 other study(ies) available for leucine and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Combination Treatment of TRPV4 Agonist with Cisplatin Promotes Vessel Normalization in an Animal Model of Oral Squamous Cell Carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Disease Models, Animal; Head and Neck Neoplasms; Leucine; Mouth Neoplasms; Neovascularization, Pathologic; Nitroquinolines; Oxides; Rats; Rats, Sprague-Dawley; Receptor, TIE-2; Squamous Cell Carcinoma of Head and Neck; Sulfonamides; TRPV Cation Channels | 2022 |
LGR5 promotes invasion and migration by regulating YAP activity in hypopharyngeal squamous cell carcinoma cells under inflammatory condition.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Head and Neck Neoplasms; Humans; Leucine; Neoplastic Processes; Receptors, G-Protein-Coupled; RNA, Small Interfering; Squamous Cell Carcinoma of Head and Neck; Verteporfin | 2022 |